Circulating biomarker concentrations were measured before and after dialysis.
We evaluated NT-proBNP, MR-proANP, MR-proADM, CT-proET-1, CT-proAVP and sST2.
Biomarkers (with the exception of sST2) were increased in hemodialysis patients.
When using a high-flux membrane, biomarkers (with the exception of sST2) decreased.
In contrast, biomarkers did not decrease markedly when using a low-flux membrane.